Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,28 USD | +8,47% | -3,03% | +122,61% |
23/04 | OCUGEN, INC. : Chardan Research ontvangt een koopadvies | ZM |
23/04 | OCUGEN, INC. : Chardan Research bevestigt koopadvies | ZM |
Vakgebied
Aantal werknemers: 65
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Shankar Musunuri
CEO | Chief Executive Officer | 60 | 01-01-13 |
Director of Finance/CFO | 42 | - | |
Jesse Simmers
CTO | Chief Tech/Sci/R&D Officer | - | - |
Huma Qamar
CTO | Chief Tech/Sci/R&D Officer | - | - |
Nirdosh Jagota
CMP | Compliance Officer | - | - |
Arun Upadhyay
CTO | Chief Tech/Sci/R&D Officer | - | 01-02-17 |
Ramesh Kumar
BRD | Director/Board Member | 68 | 27-09-19 |
J.P. Gabriel
PRN | Corporate Officer/Principal | - | - |
Michael Shine
PRN | Corporate Officer/Principal | - | 10-06-21 |
Zara Gaudioso
HRO | Human Resources Officer | - | 01-03-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 76 | 17-03-22 | |
Director/Board Member | 74 | 05-04-20 | |
Ramesh Kumar
BRD | Director/Board Member | 68 | 27-09-19 |
Shankar Musunuri
CEO | Chief Executive Officer | 60 | 01-01-13 |
Uday Kompella
FOU | Founder | 57 | 01-01-13 |
Junge Zhang
BRD | Director/Board Member | 57 | 01-09-19 |
Kirsten Castillo
BRD | Director/Board Member | 51 | 05-04-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 257 446 764 | 253 598 862 ( 98,51 %) | 121 500 ( 0,0472 %) | 98,51 % |
Aandeel B | 0 | 54 745 | 0 | 0 |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+122,61% | 329 mln. | |
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |
- Beurs
- Aandelen
- Koers OCGN
- Onderneming Ocugen, Inc.